Homepage

PRA-QHLBHQ08-0D1UP3

Dementia

  • M/F
  • 18 - 55 years old
  • Healthy

Clinical trial of a new compound that is being developed for the treatment of dementia.

Register without obligation

Very positive experience, with a very professional staff. 

Liam

Participant ICON

Register without obligation

Find out if you qualify for this trial

  • You are a healthy male or female
  • You are between 18 and 55 years old
  • You weigh more than 50 kg
  • Your Body Mass Index (BMI) is between 18 and 30.9 kg/m2

Good to know about this trial

  • Short stay (1 night per period)
  • This clinical trial partly takes place in Groningen and Utrecht
  • The study compound has previously been administered to humans

How does it work

How does it work?

  1. 1.

    Registering

    Register for the trail and the group you choose. After your registration, call ICON to discuss the study and make an appointment for your medical examination.

  2. 2.

    Medical screening

    If you meet the requirements of the trial, then a medical screening takes place at our screening center in Groningen or Utrecht.

  3. 3.

    The trial

    The clinical trial is conducted at ICON's research center in Groningen. There you will eat, sleep and stay during the trial.

  4. 4.

    Follow-up & Compensation

    A follow-up screening always takes place after the trial. You will receive the compensation for your participation, within 30 days.

Read more

Study groups

Register without obligation for the group of your preference

  • Group 1

    • 18 up to and including 23 March

    Period(s) of stay
    1 x 6 days

    • 18 up to and including 23 March

    • 25 March
    • 28 March
    • 29 March

    Visit(s) (3 days)

    • 25 March
    • 28 March
    • 29 March

    • €2333,-

    Compensation

    • €2333,-

    The follow-up appontment takes places between April 1 and April 4, 2024

     

     

    Note

    The follow-up appontment takes places between April 1 and April 4, 2024

     

     

    Full

  • Group 1a

    • 15 up to and including 20 April

    Period(s) of stay
    1 x 6 days

    • 15 up to and including 20 April

    • 22 April
    • 25 April
    • 26 April

    Visit(s) (3 days)

    • 22 April
    • 25 April
    • 26 April

    • 29 April (physically)
    • 2 May (physically)

    Follow-up(s) (2 days)

    • 29 April (physically)
    • 2 May (physically)

    • €2333,-

    Compensation

    • €2333,-
    Full

The research physician about this research

Additional information

In this clinical trial, we investigate how the study compound is processed and eliminated by the body and how well it is tolerated when it is used by healthy participants. You receive the compound once.

In part 1, you receive only the study compound, as a capsule for swallowing.

Download the research overview for part 1

Who can participate?

Target group

  • You are a healthy male or female.
  • You are at least 18 and at most 55 years old.
  • Your weight is at least 50 kg for males, and 45 kg for females. Your Body Mass Index (BMI) is at least 18.0 and not higher than 30.9 kg/m2. 
  • Both non-smokers and light smokers or occasional smokers are allowed to participate in this clinical trial (maximum of 5 cigarettes per day). During your stay in our research facility you are not allowed to smoke.

Note:

  • You cannot participate in the trial if you have participated in another clinical trial in 3 months prior to the first compound administration in this clinical trial (counting from the last dosing of the previous trial).
  • To determine if you are suitable to participate in this trial, you will undergo a medical screening. Depending on availability, this can be performed in Groningen or in Utrecht.

As a female you can only participate if you are not pregnant, not breast feeding and meet one of the following conditions:

  • You have passed the menopause (no periods for at least 12 months);
  • You have been sterilized.

As a male you can only participate if you meet one of the following conditions:

  • You are using a condom in combination with an additional contraception method used by your female partner;
  • You have been sterilized or your female partner is sterilized or has passed the menopause (no periods for at least 12 months);
  • You are not sexually active according to your lifestyle;
  • You are only sexually active with a partner of the same sex

 

 

What is the compensation for this research?

Compensation

  • For participation in part 1, you will receive a gross compensation of € 2333.

Travel expenses will be reimbursed based on the distance traveled (€ 0.21 net per kilometer) with a minimum of € 13 and a maximum of € 176.40 (840 kilometers) per round trip, regardless of the mode of transportation

How long does this research take?

Period of stay and research

  • Part 1: The trial consists of 1 period during which you will stay in the research facility in Groningen (location van Swietenlaan 6) for 6 days (5 nights), followed by 3 short visits. The follow-up visit will take place 1 to 6 days after your last departure from the research facility.

Note: You must be available for all dates to be able to participate in this clinical trial. 

Frequently asked questions

Your participation in a clinical trial is always voluntary. You can therefore decide to stop at any time. Sometimes you have to stop. For example because of family circumstances or if the doctor decides it is better for your health. If you stop, we will look at what portion of the compensation you are entitled to. It's only fair!

During the trial, you may suffer from mild symptoms like headache or nausea. That may be caused by the medication. It might also be caused by needing to fast for the trial, for example. Those side effects are no fun, but fortunately are not dangerous.

Before a medication is tested on people, it has already been studied extensively in a lab. This enables us to predict well which side effects you might get and we can prepare you for them. It almost never happens that participants suffer from unexpected side effects. For example, an allergic reaction to the medication occurs on average once a year.

You can participate in a trial a maximum of four times a year. There must be at least 30 days between two trials. Some trials have a longer waiting period.

Current trials

Participate in another study?

View all clinical trials
View all clinical trials